Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Lázaro

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Kidney International|September 20, 2024
Cilastatin, a new therapeutic promise for acute kidney injuryMaría Ángeles González-Nicolás, Alberto Lázaro
Methods in Cell Biology|January 25, 2025
Induction of sepsis in a rat model by the cecal ligation and puncture technique. Application for the study of experimental acute renal failureMaría Ángeles González-Nicolás, Alberto Lázaro
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 5, 2013
Metabolic derangements in COPD muscle dysfunctionLuis Puente-Maestu, Alberto Lázaro, Blanca Humanes
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approachAlberto Lázaro, Julio Gállego-Delgado, Julio I Osende, et al.
Methods in Cell Biology|September 10, 2025
Experimental model of unilateral ureteral obstruction reproduces key events of chronic kidney disease: From mice to humansLara Valiño-Rivas, María Ángeles González-Nicolás, Elena Vázquez-Ogando, et al.
International Journal of Laboratory Hematology|March 11, 2022
Search for the cause of anaemia and neutropenia in a patient with well-controlled systemic lupus erythematosusEdwin Uriel Suárez M, Alberto Lázaro-García, Carlos Soto, et al.
Clinical Kidney Journal|October 29, 2020
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine stormMaría Ángeles González-Nicolás, Cristian González-Guerrero, Verónica Astrid Pérez-Fernández, et al.
International Journal of Molecular Sciences|November 27, 2021
Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by CilastatinEstefanía Moreno-Gordaliza, Maria Dolores Marazuela, Óscar Pastor, et al.
Cells|May 14, 2022
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in RatsRebeca González-Fernández, María Ángeles González-Nicolás, Manuel Morales, et al.
International Journal of Molecular Sciences|March 28, 2024
Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New PerspectiveMaría Ángeles González-Nicolás, Cristian González-Guerrero, Marian Goicoechea, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Kidney International|September 20, 2024
Cilastatin, a new therapeutic promise for acute kidney injuryMaría Ángeles González-Nicolás, Alberto Lázaro
Methods in Cell Biology|January 25, 2025
Induction of sepsis in a rat model by the cecal ligation and puncture technique. Application for the study of experimental acute renal failureMaría Ángeles González-Nicolás, Alberto Lázaro
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 5, 2013
Metabolic derangements in COPD muscle dysfunctionLuis Puente-Maestu, Alberto Lázaro, Blanca Humanes
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approachAlberto Lázaro, Julio Gállego-Delgado, Julio I Osende, et al.
Methods in Cell Biology|September 10, 2025
Experimental model of unilateral ureteral obstruction reproduces key events of chronic kidney disease: From mice to humansLara Valiño-Rivas, María Ángeles González-Nicolás, Elena Vázquez-Ogando, et al.
International Journal of Laboratory Hematology|March 11, 2022
Search for the cause of anaemia and neutropenia in a patient with well-controlled systemic lupus erythematosusEdwin Uriel Suárez M, Alberto Lázaro-García, Carlos Soto, et al.
Clinical Kidney Journal|October 29, 2020
Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine stormMaría Ángeles González-Nicolás, Cristian González-Guerrero, Verónica Astrid Pérez-Fernández, et al.
International Journal of Molecular Sciences|November 27, 2021
Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by CilastatinEstefanía Moreno-Gordaliza, Maria Dolores Marazuela, Óscar Pastor, et al.
Cells|May 14, 2022
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in RatsRebeca González-Fernández, María Ángeles González-Nicolás, Manuel Morales, et al.
International Journal of Molecular Sciences|March 28, 2024
Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New PerspectiveMaría Ángeles González-Nicolás, Cristian González-Guerrero, Marian Goicoechea, et al.
Pageof 5